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Background. Scaffold surface features are thought to be important regulators of stem cell performance and endurance in
tissue engineering applications, but details about these fundamental aspects of stem cell biology remain largely unclear.
Methodology and Findings. In the present study, smooth clinical-grade lactide-coglyolic acid 85:15 (PLGA) scaffolds were
carved as membranes and treated with NMP (N-metil-pyrrolidone) to create controlled subtractive pits or microcavities.
Scanning electron and confocal microscopy revealed that the NMP-treated membranes contained: (i) large microcavities of 80–
120 mm in diameter and 40–100 mm in depth, which we termed primary; and (ii) smaller microcavities of 10–20 mm in diameter
and 3–10 mm in depth located within the primary cavities, which we termed secondary. We asked whether a microcavity-rich
scaffold had distinct bone-forming capabilities compared to a smooth one. To do so, mesenchymal stem cells derived from
human dental pulp were seeded onto the two types of scaffold and monitored over time for cytoarchitectural characteristics,
differentiation status and production of important factors, including bone morphogenetic protein-2 (BMP-2) and vascular
endothelial growth factor (VEGF). We found that the microcavity-rich scaffold enhanced cell adhesion: the cells created
intimate contact with secondary microcavities and were polarized. These cytological responses were not seen with the smooth-
surface scaffold. Moreover, cells on the microcavity-rich scaffold released larger amounts of BMP-2 and VEGF into the culture
medium and expressed higher alkaline phosphatase activity. When this type of scaffold was transplanted into rats, superior
bone formation was elicited compared to cells seeded on the smooth scaffold. Conclusion. In conclusion, surface
microcavities appear to support a more vigorous osteogenic response of stem cells and should be used in the design of
therapeutic substrates to improve bone repair and bioengineering applications in the future.
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INTRODUCTION
Engineering techniques capable of maximizing cell adhesion,
performance and differentiation onto suitable scaffolds are needed
to achieve and implement effective and efficient tissue reconstruction
protocols. Polymer surface texturing and microstructures and
physiological treatments with physical stimuli are found to ameliorate
cell adhesion and differentiation and the overall tissue regeneration
process [1,2,3]. However, clinical application of these bioengineering
approaches and procedures is likely to require further and detailed
understanding of complex interplays and interactions likely occurring
at the cell surface/substrate interface. These interactions and
interplays are likely to be mediated and affected by specific cell-
surface components and submicroscopic scaffold features including
microtextures. An example of microtextures are surface depressions
or micro concavities of different dimensions which are found to be
potentially important for stem cell differentiation [3]. It is possible
that the specific size, conformation and distribution of these
microcavities could affect the physiologic responses of stem cells
within the scaffolds, for example by enhancing membrane contacts
and cell surface exchanges; this could in turn direct their
differentiation potentials along given lineages, ultimately leading to
superior tissue production and repair [4–6]. Thus, it would be highly
desirable to have a detailed understanding of stem cell/microcavity
biology since it could lead to improved design of tissue-specific
bioengineering applications.
In any bioengineering application, the selection of the stem cell
population to be used is a critical factor. This is because stem cells
of different origin have distinct capabilities in terms of survival,
differentiation potentials, responses to experimental manipula-
tions, and ultimately performance and effectiveness in tissue
reconstruction. In previous studies, we have found that stromal
cells isolated from adult human dental pulp (SBP-DPSCs) are
multipotential and can give rise to a variety of cell types and tissues
including adipocytes, neural cell progenitors and myotubes [7–9].
The cells proliferate extensively under standard culture conditions,
have a long life-span, and maintain their multipotential capabilities
for generations. When used under specific conditions, they can
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tissue is actually remodeled to form a lamellar bone [7–8] through
co-differentiation of SBP-DPSC into osteoblasts and endotheliocytes
[10]. In this setting, SBP-DPSCs produce bone and not dentin as
showed by in vitro mRNA transcripts, their high expression of
alkaline phosphatase [7–8] – an enzyme that plays a pivotal role in
bone mineralization [11] - and in vivo histomorphometry [10].
Therefore, these cells appear to be ideal candidates for bone-tissue
reconstruction protocols and bone regeneration models.
Numerous scaffold materials, compositions and designs have
been experimented and compared over recent years [12].
Amongst them, PLGA polymers remain popular as they display
excellent biocompatibility demonstrated by absence of rejection
and inflammation [13,14]. Studies on toxicity, biocompatibility
and clinical applications in the field of orthopedics and surgery,
using implants made of polylactic acid and their copolymers, show
that the intrinsic nature of these biomaterials renders them suitable
for applications where temporary slow release of bioactive agents
in situ are required [15]. The studies suggest also that these
biomaterials are suitable for orthopaedic applications. In addition
to biocompatibility [16], the other properties of these polymers
that make them uniquely suitable for these and other applications
include: thermoplasticity, high strength, controlled crystallinity,
controlled degradation rates, controlled hydrophilicity, and proven
non toxicity [17].
In bioengineering applications, bone formation is routinely
monitored by a variety of histological, biochemical and molecular
criteria. Chief among the latter is gene expression of growth
factors [18] that are of particular importance to osteogenesis and
bone growth and remodeling. Bone morphogenetic proteins
(BMPs) are members of the transforming growth factor beta
(TGF-b) superfamily and have long been known to be of
significant importance for cartilage and bone differentiation
during endochondral or intramembranous ossification [19].
BMP-2 is a well known effector of skeletal development and
growth [18] and is also widely used for therapeutic bone
reconstruction applications [18]. With respect to other BMPs,
BMP-2 and BMP-4 are 92% identical at the amino acid level and
are, therefore, considered a subgroup within the BMP family [19].
BMPs signal via different hetero-oligomeric complexes of type I
and type II serine/threonine kinase receptors [20,21]. BMP-2
receptors include the type I receptors, ALK-6/BMPR-IB, ALK-2/
Act RI and ALK-3/BMPR-IA, and the type II receptors, BMP
RII and Act RIIB [22–25]. During endochondral development,
cartilage and bone differentiation involve a series of events that are
directly influenced by BMPs. Endochondral bone formation is not
only necessary for limb formation in embryogenesis, but is also
required for longitudinal bone growth in postnatal life and bone
regeneration following injury. BMP-2 is expressed in the growth
plate and regulates growth plate chondrogenesis by inducing
chondrocyte proliferation and hypertrophy [26,27].
Vascular endothelial growth factor (VEGF) [28], also known as
vascular permeability factor (VPF) [29] or vasculotropin [30], is
a homodimeric 34–42 kDa, heparin-binding glycoprotein with
potent angiogenic, mitogenic and vascular permeability-enhancing
activities specific for endothelial cells. The expression of VEGF is
upregulated by phorbol ester, TGF-b and in hypoxia [31–33].
Two receptor tyrosine kinases have been described as putative
VEGF receptors. Flt-1 (fms-like tyrosine kinase) [34], and KDR
(kinase-insert-domain-containing receptor) proteins have been
shown to bind VEGF with high affinity [35]. Flk-1 has been
shown to be involved in the VEGF-mediated transduction of
signals that are important for angiogenesis and vasculogenesis
[36]. In vitro, VEGF is a potent endothelial cell mitogen [28–30].
VEGF has also been shown to be chemotactic for monocytes and
osteoblasts [37]. In vivo, VEGF can induce angiogenesis and
increases microvascular permeability [28,33,37].
The present study was thus conducted to test whether the
osteogenic potentials of SBP-DPSCs would be affected by the
physical characteristics of PLGA-based substrates. Given the
presumed importance of microcavities, we prepared substrates
that were either smooth or contained microcavities of different
dimensions. We monitored a variety of cellular parameters over
time as well as the histomorphometric characteristics of bone and
production of BMP-2 and VEGF, two important bone-related
growth factors.
RESULTS
Cell/scaffold interactions
Asinpreviousstudiesfromourlaboratories,we isolated stromalstem
cells from the dental pulps (SBP-DPSCs) of healthy individuals and
sorted them to be c-Kit
+/CD34
+. After dental pulp extraction and
digestion, almost 82.360.9% of cells obtained were viable.
The cells were grown under conditions favoring their commit-
ment to the osteogenic lineage. By day 30 of culture the cells had
become Runx-2 and CD44 double-positive by cytofluorimetric
analysis as shown previously [7–9] and were also positive for Flk-1,
VEGF receptor type II [10] and BMP receptors type I and II (data
not shown).
Cells were then seeded onto PLGA 85:15 scaffolds. Scanning
electron and confocal microscopy revealed that NMP (N-methyl-
pyrrolidone)-treated scaffolds contained two types of concave
microcavities: (i) large microcavities 80–120 mm in diameter and
40–100 mm in depth which we termed ‘‘primary’’ (Fig. 1A,B, red
arrows); and (ii) smaller microcavities 10–20 mm in diameter and
from 3–10 mm in depth, located within the primary cavities and
thus termed ‘‘secondary’’ (Fig. 1A,B, red arrowheads) (see Fig 2D for
schematic representation of distribution of primary and secondary
microcavities). Membranes that were not treated with NMP had
their original smooth surface characteristics (not shown). Cell
plating efficiency tests showed that about 90% of osteogenic SBP-
DPSC cells adhered to microcavity-containing NMP-treated
surfaces as well as to culture flasks within 12 hrs, while about
80% adhered to smooth untreated surfaces. The approximate
division time was about 2.4 days and it was the same both for cells
grown in culture flasks and for cells on the scaffolds.
Given their large dimensions, primary microcavities were able to
fully contain cells as shown by scanning and confocal microscopy
(Fig. 1A,D,E, green arrows). The cells usually appeared to adhere
and spread on the secondary microcavities, covering one or more
of them (Fig. 1E: cells in green; secondary microcavities in blue; and primary
microcavity in red). As a result, the nucleus was often off center and
the cells seemed to be polarized and displayed spider-like
protrusions spreading away in certain directions (Fig. 1D,E). The
ability to relate closely and surround the secondary microcavities
appeared to be a preferential property of the osteogenic cells, since
it was not normally seen with human gingival fibroblasts; when
grown under identical conditions, these fibroblasts displayed a flat
and nondescript cytoarchitecture (Fig. 1F). A similar non-descript
morphology was seen when osteogenic SBP-DPSC cells were
seeded and grown onto smooth scaffold (Fig. 2A–C).
Expression of osteogenic markers in vitro
To determine whether cell-to-cell scaffold interactions modify
phenotypic expression, SBP-DPSC cells were monitored for
expression of alkaline phosphatase activity (ALP) at 24, 48, 72
and 96 hours after plating. ALP is an enzyme that is particularly
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deposition. Indeed, we observed that ALP was consistently greater
in cells plated onto the microcavity-rich substrate (Fig. 3). Gingival
fibroblasts did not express ALP.
We then analyzed production and release of BMP-2 and VEGF,
factors important for osteogenesis. Greater amounts of VEGF and
BMP-2 were present in medium conditioned by cells grown on the
microcavity-textured surface, and particularly at 72 and 96 hrs
(Fig 4A,B), when compared to amounts present in the medium
conditioned by cells on smooth surfaces (Fig 4C, D). Total overall
amounts of BMP-2 and VEGF were consistently higher in
microcavity rich- than smooth-surface grown cultures. Gingival
fibroblasts did not express BMP2 and VEGF.
In vivo bone formation
To test the possible influences of surface characteristics on bone
formation in vivo, SBP-DPSC cells were first grown for about 35
days in monolayer as above and were then seeded onto smooth or
concave microtextured scaffolds. Four days later, the colonized
scaffolds were grafted into immunocompromised rats, retrieved
and analyzed after 30, 45 and 60 days from transplantation.
Histological examination indicated that bone tissue had formed on
both substrates by day 30 (not shown) and had further remodeled
by day 60 into lamellar bone containing osteocytes entrapped
within the lamellae when on the microtextured scaffold (Fig. 5A).
Tissue present on day 60 on smooth scaffolds appeared to be more
Figure 1. Images showing primary and secondary micro concavities at scanning electron and confocal microscopy. (A) Primary micro concavity
(arrow) of the PLGA surface at SEM. Cells can be completely contained within a primary concavity, due to its dimensions. (Calibration Bar=10 mm); (B)
SEM analysis of primary concavity dimensions (Calibration Bar=10 mm); (C) SEM analysis of secondary concavity dimensions (Calibration Bar=10 mm);
(D) The interaction between the concave surface, showing primary (white arrow) and secondary (red arrows) micro-concavities at the confocal
microscope (in green a cell within a concavity). The intimate adherence of a cell to the polymer surface and its nuclear polarity are clearly observable.
The image was been obtained superimposing dark field with light field confocal microscopy (Calibration Bar=10 mm); (E) Confocal image showing
primary (outlined in red) and secondary (outlined in blue) micro-concavities and spider-shaped cellular elongations (Calibration Bar=10 mm); (F)A
gingival fibroblast not showing cellular alterations or nuclear polarity at the confocal microscope (Calibration Bar=10 mm).
doi:10.1371/journal.pone.0000496.g001
Figure 2. Images showing the results obtained when cells were cultured on the smooth surface. (A) smooth surface at SEM (Calibration
Bar=10 mm); (B) cells, cultured on a smooth surface, under SEM, show an elongated shape (Calibration Bar=10 mm); (C) confocal image showing the
relationship between cells and the smooth surface (Calibration Bar=10 mm); (D) image showing the relationship between cells and the different
surface texturing: (1) concave and (2) smooth.
doi:10.1371/journal.pone.0000496.g002
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48, 72 and 96 hours within the cells cultured on the different surfaces. The data have been rounded to the closest integer value. The error bars are
6SD.*p,0.01. Each experiment was performed in triplicate (n=3).
doi:10.1371/journal.pone.0000496.g003
Figure 4. ELISA assays performed on (A) VEGF and (B) BMP2 released within the supernatant by SBP-DPSCs after 24, 48, 72 and 96h from plating
on smooth and concave textured surface; ELISA assays performed on (C) VEGF and (D) BMP2 present in the cell layer of SBP-DPSCs after 24, 48,
72 and 96h from plating on smooth and concave texturing. Each experiment was performed in triplicate (n=3). The error bars are 6SD. *p,0.01. N
indicates samples not NMP-treated; P indicates NMP-treated samples.
doi:10.1371/journal.pone.0000496.g004
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the bone was confirmed HLA-1 immunofluorescence (Fig. 6).
Immunohistochemistry showed presence of mineralized extra-
cellular matrix in day 60 microcavity-rich samples that contained
bone markers including collagen I, BAP, OC and ON (Fig. 7A,B,
C,D). BSP was particularly abundant along the scaffold’s edge,
indicating possible sites of proliferation and tissue neoformation
(Fig. 7E). Performance of cells on the smooth surface was not as
vigorous both in terms of immunofluorscence signal intensities and
bone tissue thickness (Fig. 7F, G, H, I, J).
DISCUSSION
In this study we present evidence that dental pulp-derived stromal
stem cells behave and respond differently when exposed to
microcavity-rich versus smooth PLGA substrates. The concave
texturing of the substrate elicits cytoarchitectural responses and
adaptation in which the cells appear to favour intimate contacts
with the secondary microcavities and cellular polarization. Such
behaviour is accompanied by increased release of BMP-2 and
VEGF into the culture medium and by higher ALP activity. It is
likely that increased release of potent factors such as BMP-2 and
VEGF and the higher ALP activity could have significant
biological ramifications. By their proven involvement and potency
in bone formation and angiogenesis, these factors and enzymatic
activity may influence the responses and developmental program
of stromal-derived cells via autocrine mechanisms and also
influenced by surrounding cells via paracrine pathways. In this
likely scenario, increased levels of BMP-2 and VEGF could be
responsible for the greater amounts of bone tissue we observe after
transplantation of the colonized microcavity-rich scaffold.
The coordinated increase in BMP-2 and VEGF levels suggest
that a relationship exists between them during osteogenesis, as
previously hypothesized [38]. It is well known that vasculogenesis
is of critical importance for bone development and healing [39,40]
and that vessel sprouting is closely linked to bone formation during
physiological bone development. This reciprocal interplay is
regulated by a BMP-2-VEGF cross-talk. Thus, these factors may
induce formation of a bone tissue containing a suitable number of
vessels that will ensure a sufficient bone feeding [39–41]. Thanks
to a high pO2 and nutrient concentration, bone then carries on
mineralization and maturation process. The VEGF and BMP-2
levels found in our study suggest that the concave-textured surface
of the PLGA constructs may facilitate the release of more
biologically-relevant and coordinated amounts of these two factors
when compared to the amounts released by cultures grown on
smooth surfaces.
It is interesting to note that primary micro concavity diameters
are similar to those seen in medullary trabecular spaces, while
secondary micro concavities resemble niches in the stromal bone
marrow, the regulatory depressions for hematopoiesis and
ossification. It is conceivable that the structural features of the
microcavity-rich surface may have somehow enabled the stromal
cells to react more vigorously and favorably then the smooth
surface. As stated above, cells on concave texturing are more
Figure 5. Haematoxilin and Eosin staining. (A) In vivo sample on concave PLGA scaffold (Calibration Bar=10 mm). The figures shows that the bone
tissue is of great thickness with an evident periosteal layer (red arrow) and containing osteocytes entrapped within the matrix (black arrows). (B) In
vivo sample on smooth PLGA scaffold (Calibration Bar=5 mm) appeared to be more primitive, thin (black arrow) and not as well developed above
a connective loose tissue containing vessels (red arrow).
doi:10.1371/journal.pone.0000496.g005
Figure 6. Immunofluorescence for HLA-1 Human FITC (green) (A) In vivo concave PLGA scaffold. (B) In vivo smooth PLGA scaffold. (Calibration
Bars=5 mm). Nuclear staining is obtained with DAPI (blue).
doi:10.1371/journal.pone.0000496.g006
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extensions and appear to have a nuclear polarity that may
represent an index of secretion and of other cellular activities, such
as matrix formation. These parameters do not characterize the
same cell populations plated onto smooth surfaces nor do they
characterize gingival fibroblasts plated onto microcavity-rich
substrate. It may then be that by mimicking in vivo microstructural
features and niches, the microcavity-rich substrate may have
prodded stromal-derived cells toward osteogenic differentiation
and a more vigorous developmental response and outcome.
When a cell sits in a microcavity, when compared with the same
cell laying on a flat surface, for the adhesion processes it recruits
a higher number of integrins per volumetric unit [5], as it is easily
conceivable measuring the area of a circle and the area of an
Figure 7. Immunofluorescence confirming the presence of a mineralized extra cellular matrix on concave texturing. The panel shows positivity
for Collagen I (A) FITC (green) (Calibration Bar=10 mm), BAP [Bone Alkaline Phosphatase] (B) FITC (green) (Calibration Bar=5 mm), OC [Osteocalcin]
(C) PE (red) (Calibration Bar=7 mm), ON [Osteonectin] (D) FITC(green) (Calibration Bar=7 mm) and BSP [Bone Sialoprotein] (E) PE (red) (Calibration
Bar=3 mm). The same analysis confirming the presence of a mineralized extra cellular matrix on smooth texturing. The panel shows positivity for
Collagen I (F) FITC (green) (Calibration Bar=5 mm), BAP (G) FITC (green) (Calibration Bar=7 mm), OC (H) PE (red) (Calibration Bar=3 mm), ON (I) FITC
(green) (Calibration Bar=7 mm) and BSP (J) PE (red) (Calibration Bar=3 mm). Nuclear staining is obtained with DAPI (blue).
doi:10.1371/journal.pone.0000496.g007
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integrins involved, the higher the number of focal adhesion kinases
activated, with an increased exposition to mechanical stresses
acting both on the cell and scaffold surface; moreover, as
a microwell-plate, the microcavities make easier the interaction
of the cell receptors with soluble factors released by cells,
influencing their fate [42].
In conclusion, micro-concavities (subtractive pits texturing) elicit
superior outcomes in terms of osteodifferentiation, cell maturation
and specific protein production, leading to a neoformation of bone
tissue of significant thickness. This information could be used to
design new scaffolds for bone tissue engineering with textures
capable of promoting more effective healing of bone and
mineralization defects.
MATERIALS AND METHODS
Dental pulp extraction and digestion
Human dental pulp was extracted from teeth of healthy adult
subjects aged 20 to 45 years. Before extraction, each subject was
checked for systemic and oral infection or diseases. Only disease-
free subjects were selected for pulp collection. Each subject was
pre-treated for a week with professional dental hygiene. Before
extraction, the dental crown was covered with a 0.3% chlorexidin
gel (Forhans, N.Y., USA), for 2 min. Dental pulp was gently
removed by means of a dentinal excavator or a Gracey curette,
immersed in a digestive solution containing penicillin 100 U/ml,
streptomycin 100 mg/ml, 0.6 ml claritromycin 500 mg/ml, 3 mg/
ml type I collagenase and 4 mg/ml dispase in PBS, and incubated
for 1 h at 37uC. Following this incubation, the digested tissue
mixture was filtered through a 70 mm Falcon strainer (Becton &
Dickinson, Franklin Lakes, NJ, USA) to obtain a single cell
suspension.
Cell culture
After filtration, the cells were placed in a-MEM culture medium
supplemented with 20% FCS, 100 mM 2P-ascorbic acid, 2 mM L-
glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin (all
purchased from Invitrogen, San Giuliano Milanese, Milan, Italy)
and placed in 75 cm
2 flasks with filtered caps. Flasks were
incubated at 37uC in humidified atmosphere containing a 5%
CO2 and medium was changed twice a week. After cell con-
fluence, the cells were subdivided into new flasks and passaged
a total of 10 times. Human gingival fibroblasts were collected
during periodontal surgery and cultured as above.
FACScanning, sorting and differentiation
As previously specified [7,8], we sorted cells using both morpho-
logical traits (high side scatter and low forward scatter) and
antigenic criteria (firstly using CD117 and CD34, and then serially
using STRO-1 and flk-1). Only cells that expressed all these
markers were selected in order to obtain a homogeneous popula-
tion, called SBP-DPSC.
Briefly, cells were detached using 0.02% EDTA in PBS and
pelleted (10 min at 1,000 rpm), washed in 0.1% BSA in 0.1 M
PBS at 4uC and incubated in a solution of 1 ml antibody/9 ml
0.1% BSA in 0.1 M PBS. Cells were washed in the same solution
once and were processed for sorting (FACsorter, Becton &
Dickinson, Franklin Lakes, NJ, USA). The mouse anti-human
antibodies CD117 (c-kit), CD34, flk-1 and STRO-1 were from Dr.
Torok-Storb through DBA, Segrate, Milan, Italy.
Osteogenic differentiation was achieved as reported by Laino
et al. [7,8]. Briefly, SBP-DPSCs were cultured with 20% FBS for
15 days without passaging, after which cells were cultured with
20% FBS for the rest of the experiment.
To monitor differentiation, the cells were examined using
mouse anti-human antibodies to CD44, the transcription factor
RUNX-2 (all from Santa Cruz, CA, USA), type I and II BMP
receptors (BMPr I–II) and VEGF receptor type II (Flk-1). For
RUNX-2 analysis, cells were fixed in 4% paraformaldehyde in
0.1 M PBS and 0.2% Triton X-100 for 30 min at 4uC, washed
twice in 0.1% BSA in 1M PBS and then incubated with RUNX-2
antibody.
Substrate design and cultures
To obtain scaffold with two surface texturing, PLGA 85:15 was
carved as membranes (INION, Finland). (A) a smooth surface was
obtained using PLGA membrane as sold by the manufacturer; and
(B) a concave texturing was obtained treating the membrane with
NMP, a chemical agent (by the same manufacturer) that is able to
create controlled subtractive pits on the surface following
manufacturer’s instructions.
Aliquots of 100,000 SBP-DPSCs (CD44
+/RUNX-2
+) were
gently plated on the scaffolds and cultured for 96 h in order to
observe cell-substrate adhesion and protein expression. Gingival
fibroblasts were used as control for each substrate. Plating
efficiency assays were performed counting free-floating cells
12 hours after plating.
After 96 h scaffolds and cultured cells were transplanted into
animals. Experiments were repeated at least four times.
Scanning electron microscope analysis
After 96 h of culture, cells were fixed in 2.5% glutaraldehyde (EM
grade) in 0.1 M phosphate buffer, postfixed in 0.1% OsO4 in the
same buffered solution for 1 h and, after critical point drying and
gold-palladium coating, were observed under a Scanning Electron
Microscope (JEOL-6700F, Tokyo, Japan).
Confocal microscopy
After 96 h of culture, cells were fixed for 15 min at room
temperature using 4% paraformaldehyde and permeabilized with
0.2% Triton X-100 in 0.1 PBS, washed twice with 0.1 M PBS for
10 min at room temperature and incubated for 30 min with
phalloidin-FITC (Sigma, Milan, Italy), then washed with 0.1 M
PBS for 10 min and stained for 2 min with Hoechst Blue (Sigma,
Milan, Italy). Cells were washed twice with 0.1 M PBS and then
observed on a Zeiss LSM510 confocal microscopy (Carl Zeiss,
Go ¨ttingen, Germany).
In vitro histochemistry
For alkaline phosphatase (ALP), samples of 100,000 differentiated
SBP-DPSCs (CD44+/RUNX-2+) were detached after 24, 48, 72,
96 hours by treatment with PBS/EDTA (0.02%) and centrifuged
for 10 min at 140 6 g. The pellet was incubated with 1 ml of
BMPurple solution (Roche, Segrate, Milan, Italy) for 8 hours in
the dark. Supernatant absorbance was measured at 615 nm using
a spectrophotometer. As a control, human ginigival fibroblasts
cultured on scaffolds were used. Values are expressed as the ratio
between sample and BMPurple stock solution. BMPurple solvent
was used as blank.
BMP2 and VEGF ELISA analyses
In order to evaluate BMP-2 and VEGF levels within the cell layer,
after 48, 72, 96 hours from plating onto scaffolds, all the cell layer
(4610
6 cells/sample) of SBP-DPSCs (CD44+/RUNX-2+) were
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150 mM NaCl, 0.1% SDS, 0.5% Triton X-100, 0.25% Na-
deoxycholate, 1 mM sodium orthovanadate) with 1 mg/ml
leupeptin (Sigma), 1 mg/ml pepstatin (Sigma), 1 mg/ml aprotinin
(Sigma), and 1 mM PMSF (Sigma). Samples were centrifuged
(16,000 6 ga t4 uC for 20 minutes) and supernatant was
precleared on an orbital shaker for 1 h at 4uC with protein-A
acrylic beads (Sigma). Following centrifugation (5 min at
12,000 g), protein contents of the supernatants were determined
using the Bradford reagent (Bio-Rad, Milan Italy) at 595 nm.
Aliquots of 0.5 ml were collected from each sample and analyzed
with an ELISA kit for BMP2 or anti-VEGF (R&D, Milan, Italy).
In order to evaluate BMP-2 and VEGF levels in the culture
medium, the complete supernatant medium was collected from
cultures after 24, 48, 72 and 96 hours from plating (4610
6 cells/
sample) SBP-DPSCs onto scaffolds. After centrifugation to remove
particulates, aliquots of 2 ml were stored at 220uC. After thawing
at room temperature, 0.5 ml were collected from aliquots and
analyzed with ELISA kit for BMP2 or anti-VEGF (R&D, Milan,
Italy). As a control, human ginigival fibroblasts cultured on
scaffolds were used.
In vivo transplantation
PLGA membranes colonized with differentiated SBP-DPSCs
(CD44
+/RUNX-2
+)( 4 610
6 cells/sample) for 96 h were trans-
planted into the dorsal surface (i.e. subcutaneously) of 10–12 week
Wistar rats (Charles River Laboratories Italia S.p.A., Calco,
Lecco, Italy). Animals were immunocompromised using Cyclo-
sporine A (Sandimmun, Novartis Pharma S.p.A., Origgio, Varese,
Italy) at a dosage of 15 mg/kg body weight, administered 4 h
before transplantation and then daily till sacrifice. During the two
weeks following surgery, daily dosages were reduced gradually
down to 6 mg/kg body weight. Transplants were recovered 30, 45
and 60 days after transplantation. All the above-mentioned
procedures were approved by institutional small animal ethics
committee.
Histology and immunofluorescence
Transplants were fixed in 4% paraformaldehyde in PBS for 48 h
at 4uC pH 7.4, decalcified for 7 days in 10% EDTA in PBS at RT
and then washed in PBS pH 7.4 at 4uC, dehydrated, embedded in
paraffin and sectioned (5 mm thick). For histological analysis slides
were deparaffinized, hydratated and stained with hematoxylin-
eosin and Mallory staining. For immunofluorescence, sections
were deparaffinized, hydratated, washed again in 0.1 M PBS, and
then blocked in 3% FBS in 0.1 M PBS at room temperature.
Mouse anti-human monoclonal antibodies were the following:
bone alkaline phosphatase (BAP), osteonectin (US Biological,
Swampscott, MA); anti-osteocalcin, anti-osteonectin, anti-BSP and
anti- Collagen I (Santa Cruz, CA) were goat anti-human. The
secondary antibodies were goat anti-mouse and mouse anti-goat
(both FITC conjugated, Santa Cruz). In addition, to evaluate cell
distribution inside tissues, DAPI counterstaining was performed.
Samples were observed under fluorescence microscopy (X41,
Olympus Optical Co. Europe, Hamburg, Germany). The
specificity of each antibody was assessed by reacting the above
mentioned antibodies with human bone samples from a mandible.
Isotype-matched antibodies were used at the same concentrations
as negative controls.
Statistical analysis
Student t-test (two-tailed) was used for statistical evaluation. Level
of significance was set at p,0.05.
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